drugset / Trial / NCT02633618

Analgecine for the Treatment of Neuropathic Pain

NCT02633618

Phase 3 Completed 135 enrolled VanWorld Pharmaceutical (Rugao) Company Limited
RandomizedParallel-groupOpen-labelTreatment

Summary

A randomized, open-label , positive drug controlled (Neurotropin,Japan organs Pharmaceutical Co., Ltd. ), multi-center study to evaluate Analgecine's efficacy and safety for the treatment of neuropathic pain.

Timeline

Start
2005-08
Primary completion
2005-12
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Analgecine Unknown 3 ml Other
Comparator Neurotropin Unknown 3 ml Other

Indications